T and B Cell Receptor Immune Repertoire Analysis using Next-generation Sequencing
January 12th, 2021
7.6K views
The current protocol describes a method for DNA isolation from blood samples and intestinal biopsies, generation of TCRβ and IGH PCR libraries for next-generation sequencing, performance of a NGS run and basic data analysis.
Overview
This protocol outlines a method for isolating DNA from blood samples and intestinal biopsies, generating TCR尾 and IGH PCR libraries for next-generation sequencing (NGS), and performing basic data analysis. It enables the exploration of T and B cell dynamics at the nucleotide or amino acid level, facilitating the identification of unique clones across different anatomical sites.
Key Study Components
Area of Science
- Immunology
- Genomics
- Next-Generation Sequencing
Background
- Next-generation sequencing allows for detailed analysis of lymphocyte populations.
- This method can reveal dynamic changes in immune responses across various disorders.
- Identifying unique T or B cell clones can lead to novel biomarker discovery.
- The procedure is demonstrated by a research assistant in the laboratory.
Purpose of Study
- To isolate DNA from biological samples for sequencing.
- To analyze T and B cell diversity in different diseases.
- To track immune cell clones in various anatomical locations.
Methods Used
- Isolation of DNA from blood and intestinal biopsies.
- Generation of TCR尾 and IGH PCR libraries.
- Execution of next-generation sequencing runs.
- Basic data analysis of sequencing results.
Main Results
- Successful isolation of DNA from samples.
- Generation of libraries suitable for NGS.
- Identification of unique T and B cell clones.
- Insights into lymphocyte diversity in various disorders.
Conclusions
- This method enhances the understanding of immune dynamics.
- It provides a framework for identifying biomarkers in diseases.
- The approach can be adapted for various research applications.
Frequently Asked Questions
What is the significance of TCR尾 and IGH PCR libraries?
They allow for the analysis of T and B cell receptor diversity, which is crucial for understanding immune responses.
How can this method help in disease research?
By tracking specific immune cell clones, researchers can identify changes associated with different disorders.
What types of samples can be used for DNA isolation?
Blood samples and intestinal biopsies are suitable for this protocol.
What are the storage conditions for intestinal biopsies?
They can be stored at -20 or -80 degrees Celsius.
Who demonstrates the procedure in the video?
Naomi Salamon, a research assistant, demonstrates the procedure.
What is the advantage of next-generation sequencing?
It allows for the identification of unique T or B cell clones and tracking them across different sites.
Executive Industry Relevance
T and B cell receptor immune repertoire analysis via next-generation sequencing provides biopharma R&D with a high-resolution view of adaptive immune dynamics, enabling mechanistic de-risking in target validation and biomarker discovery. By quantifying clonality, gene usage, and repertoire diversity across disease states, the method supports predictive confidence in early discovery and translational decision-making. This capability is directly applicable to immunology-focused pipelines seeking to link immune responses to therapeutic outcomes in inflammatory, infectious, oncologic, and autoimmune conditions.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses by tracking antigen-specific T and B cell clones across anatomical sites and timepoints.
- Operational Value: Provides nucleotide- or amino acid-level resolution of immune repertoires to clarify functional target engagement and biological de-risking.
- Predictive Value: Supports portfolio triage by identifying clonally expanded populations that correlate with disease phenotype or treatment response.
Screening & Assay Development
- Scientific Value: Generates standardized, quantitative immune repertoire profiles suitable for assay standardization and reproducibility assessment.
- Operational Value: Enables preparation of validated biological systems from blood and tissue for downstream screening workflows.
- Technical Value: Produces clonality and diversity metrics that serve as reliable readouts for compound or biologic screening campaigns.
Translational & Preclinical Research
- Translational Value: Maintains continuity from discovery through preclinical validation by tracking clonal dynamics in disease-relevant systems.
- Biomarker Alignment: Facilitates identification of shared or expanded clones across patients, supporting translational biomarker discovery in immune-mediated disorders.
- Risk-Adjusted Advancement: Informs go/no-go decisions by revealing differential VDJ gene usage and clonal expansion patterns linked to pathophysiology.
Pipeline & Workflow Integration
The method integrates into the discovery continuum from early target validation through lead identification and preclinical studies, particularly in immunology and immuno-oncology pipelines where immune mechanism de-risking is critical.
- Discovery Biology: Supports hypothesis testing and pathway clarification by revealing antigen-driven clonal selection and expansion in T and B cell compartments.
- Screening: Enables assay readiness through standardized library preparation and sequencing of TCR and IGH repertoires from isolated DNA.
- Analytics: Delivers quantitative outputs including clonality, gene family usage (V, D, J), and unique clone tracking for comparative condition analysis.
- Translational Research: Connects to preclinical continuity by enabling longitudinal tracking of immune clones in blood and tissue compartments.
- Enterprise Reuse: Functions as a reusable platform capability applicable across multiple disease areas and sample types after protocol adaptation.
Operational & Enterprise Impact
- Scientific Value: Reduces mechanistic ambiguity in immune-mediated target validation through direct measurement of repertoire dynamics.
- Operational Value: Ensures standardization and reproducibility via controlled DNA isolation, library prep, and NGS workflows.
- Strategic Value: Improves capital efficiency by enabling early identification of immunologically active clones, reducing late-stage biological risk.
- Portfolio Impact: Supports risk-adjusted prioritization by linking immune repertoire changes to disease mechanisms and therapeutic intervention.
Implementation Considerations
- Requires expertise in immunogenomics, NGS library preparation, and bioinformatic analysis of immune repertoire data.
- Dependent on access to NGS sequencers, magnetic bead-based purification systems, and controlled laboratory environments for DNA handling.
- Necessitates cross-team standardization between immunology, genomics, and data science units for consistent repertoire analysis.
- Requires adaptation of tissue digestion protocols for non-intestinal organs while maintaining DNA yield and integrity.
- Practical limitations include input DNA quantity requirements and potential bias from PCR amplification during library preparation.
Biopharma FAQs
Why does tracking unique T or B cell clones matter for target validation?
Tracking unique clones via nucleotide or amino acid sequencing enables researchers to confirm antigen-specific lymphocyte expansion, which directly supports mechanistic validation of therapeutic targets in immune-mediated diseases.
How does isolating DNA from blood and intestinal biopsies fit the discovery pipeline?
DNA isolation from matched blood and tissue samples enables comparative repertoire analysis across anatomical sites, supporting early discovery efforts to link immune changes to disease localization and target engagement.
What do quantitative measurements of clonality and gene usage enable in preclinical research?
Quantitative assessment of clonality, VDJ gene usage, and repertoire diversity provides measurable biomarkers to stratify disease states and evaluate therapeutic impact in preclinical models.
Why are replication requirements important for cross-functional collaboration in immune repertoire studies?
Replication ensures that observed clonal expansions and gene usage patterns are consistent across samples and experiments, which is essential for aligning immunology, translational, and clinical teams on biomarker validity.
What statistical analysis capabilities are required before implementing immune repertoire sequencing in R&D workflows?
Implementation requires bioinformatic tools capable of analyzing clonality, diversity indices, and statistical significance of clonal frequency changes between conditions to support data-driven decision-making.
